This change only applies to weight loss drugs (e.g., GLP-1 and non-GLP-1 drugs) when they are prescribed solely for weight loss and not for any other medical conditions that the FDA has approved them for, the company said in a statement
All articles, descriptions, technical data, educational content, and product information provided on this website are offered for informational and educational purposes only and do not constitute medical, clinical, pharmaceutical, or professional advice of any kind
If spotting persists beyond 6 months, is heavy, or happens after periods of stability, evaluate with your OB/GYN
Highly recommended for reasonably priced medicines Medha Joshi Reviewed on 07-03-2024 (5/5) GRACE DERMA HEALTHCARE PRIVATE LIMITED Country of Origin - India Issue with Content
Cota, D